The results of the present study suggest that, at a short term horizon of one year, the systematic CRAG screening (for targeted treatment of positive cases) in patients with CD4+ cell counts <100 cells/μl presenting to care in Cambodia, is more cost effective for cryptococcosis prevention compared to the systematic primary prophylaxis strategy. The gene discussed is CD4; the disease is cryptococcosis.